TY - JOUR AU - Borgna-Pignatti, C. AU - Cappellini, M. D. AU - De Stefano, P. PY - 2005 DA - 2005// TI - Survival and complications in thalassemia JO - Ann N Y Acad Sci VL - 1054 UR - https://doi.org/10.1196/annals.1345.006 DO - 10.1196/annals.1345.006 ID - Borgna-Pignatti2005 ER - TY - CHAP AU - Roberts, D. J. AU - Brunskill, S. J. AU - Doree, C. PY - 2007 DA - 2007// TI - Oral deferiprone for iron chelation in people with thalassaemia BT - Cochrane Database Syst Rev ID - Roberts2007 ER - TY - JOUR AU - Maggio, A. AU - Filosa, A. AU - Vitrano, A. PY - 2011 DA - 2011// TI - Iron chelation therapy in thalassemia major: A systematic review with meta-analyses of 1520 patients included on randomized clinical trials JO - Blood Cells Mol Dis VL - 47 UR - https://doi.org/10.1016/j.bcmd.2011.07.002 DO - 10.1016/j.bcmd.2011.07.002 ID - Maggio2011 ER - TY - JOUR AU - Davis, B. A. AU - Porter, J. B. PY - 2000 DA - 2000// TI - Long-term outcome of continuous 24-hour deferoxamine infusion via indwelling intravenous catheters in high-risk beta-thalassemia JO - Blood VL - 95 ID - Davis2000 ER - TY - JOUR AU - Davis, B. A. AU - O’Sullivan, C. AU - Jarritt, P. H. AU - Porter, J. B. PY - 2004 DA - 2004// TI - Value of sequential monitoring of left ventricular ejection fraction in the management of thalassemia major JO - Blood VL - 104 UR - https://doi.org/10.1182/blood-2003-08-2841 DO - 10.1182/blood-2003-08-2841 ID - Davis2004 ER - TY - JOUR AU - Anderson, L. J. AU - Westwood, M. A. AU - Holden, S. PY - 2004 DA - 2004// TI - Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance JO - Br J Haematol VL - 127 UR - https://doi.org/10.1111/j.1365-2141.2004.05202.x DO - 10.1111/j.1365-2141.2004.05202.x ID - Anderson2004 ER - TY - JOUR AU - Pennell, D. J. AU - Berdoukas, V. AU - Karagiorga, M. PY - 2006 DA - 2006// TI - Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis JO - Blood VL - 107 UR - https://doi.org/10.1182/blood-2005-07-2948 DO - 10.1182/blood-2005-07-2948 ID - Pennell2006 ER - TY - JOUR AU - Tanner, M. A. AU - Galanello, R. AU - Dessi, C. PY - 2007 DA - 2007// TI - A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance JO - Circulation VL - 115 UR - https://doi.org/10.1161/CIRCULATIONAHA.106.648790 DO - 10.1161/CIRCULATIONAHA.106.648790 ID - Tanner2007 ER - TY - JOUR AU - Tanner, M. A. AU - Galanello, R. AU - Dessi, C. PY - 2008 DA - 2008// TI - Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction JO - J Cardiovasc Magn Reson VL - 10 UR - https://doi.org/10.1186/1532-429X-10-12 DO - 10.1186/1532-429X-10-12 ID - Tanner2008 ER - TY - JOUR AU - Maggio, A. AU - Vitrano, A. AU - Capra, M. PY - 2009 DA - 2009// TI - Improving survival with deferiprone treatment in patients with thalassemia major: a prospective multicenter randomised clinical trial Under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies JO - Blood Cells Mol Dis VL - 42 UR - https://doi.org/10.1016/j.bcmd.2009.01.002 DO - 10.1016/j.bcmd.2009.01.002 ID - Maggio2009 ER - TY - JOUR AU - Pennell, D. J. AU - Porter, J. B. AU - Cappellini, M. D. PY - 2010 DA - 2010// TI - Efficacy of deferasirox in reducing and preventing cardiac iron overload in beta-thalassemia JO - Blood VL - 115 UR - https://doi.org/10.1182/blood-2009-04-217455 DO - 10.1182/blood-2009-04-217455 ID - Pennell2010 ER - TY - JOUR AU - St Pierre, T. G. AU - Clark, P. R. AU - Chua-Anusorn, W. PY - 2004 DA - 2004// TI - Non-invasive measurement and imaging of liver iron concentrations using proton magnetic resonance JO - Blood VL - 105 UR - https://doi.org/10.1182/blood-2004-01-0177 DO - 10.1182/blood-2004-01-0177 ID - St Pierre2004 ER - TY - JOUR AU - Ghugre, N. R. AU - Enriquez, C. M. AU - Gonzalez, I. PY - 2006 DA - 2006// TI - MRI detects myocardial iron in the human heart JO - Magn Reson Med VL - 56 UR - https://doi.org/10.1002/mrm.20981 DO - 10.1002/mrm.20981 ID - Ghugre2006 ER - TY - JOUR AU - He, T. AU - Gatehouse, P. D. AU - Smith, G. C. PY - 2008 DA - 2008// TI - Myocardial T2* measurements in iron-overloaded thalassemia: an in vivo study to investigate optimal methods of quantification JO - Magn Reson Med VL - 60 UR - https://doi.org/10.1002/mrm.21744 DO - 10.1002/mrm.21744 ID - He2008 ER - TY - CHAP AU - Meloni, A. AU - Rienhoff, H. Y. AU - Jones, A. PY - 2013 DA - 2013// TI - The use of appropriate calibration curves corrects for systematic differences in liver R2* values measured using different software packages BT - Brit J Haematol ID - Meloni2013 ER - TY - JOUR AU - Kirk, P. AU - Roughton, M. AU - Porter, J. B. PY - 2009 DA - 2009// TI - Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major JO - Circulation VL - 120 UR - https://doi.org/10.1161/CIRCULATIONAHA.109.874487 DO - 10.1161/CIRCULATIONAHA.109.874487 ID - Kirk2009 ER - TY - JOUR AU - Porter, J. B. AU - Davis, B. A. PY - 2002 DA - 2002// TI - Monitoring chelation therapy to achieve optimal outcome in the treatment of thalassaemia JO - Best Pract Res Clin Haematol VL - 15 UR - https://doi.org/10.1016/S1521-6926(02)90214-8 DO - 10.1016/S1521-6926(02)90214-8 ID - Porter2002 ER - TY - JOUR AU - Cappellini, M. D. AU - Cohen, A. AU - Piga, A. PY - 2006 DA - 2006// TI - A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia JO - Blood VL - 107 UR - https://doi.org/10.1182/blood-2005-08-3430 DO - 10.1182/blood-2005-08-3430 ID - Cappellini2006 ER - TY - JOUR AU - Koren, G. PY - 1989 DA - 1989// TI - The effects of subcutaneous deferoxamine administration on renal function in thalassemia major. International Journal of Hematology JO - Int J Hematol VL - 54 ID - Koren1989 ER - TY - JOUR AU - Koren, G. AU - Bentur, Y. AU - Strong, D. PY - 1989 DA - 1989// TI - Acute changes in renal function associated with deferoxamine therapy JO - Am J Dis Child VL - 143 ID - Koren1989 ER - TY - CHAP AU - El-Sharkawi, D. AU - Davis, B. AU - Porter, J. PY - 2008 DA - 2008// TI - The effects of 24 hour continuous deferoxamine intensification on serum creatinine BT - Blood ID - El-Sharkawi2008 ER -